BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26685181)

  • 21. Diabetes: Prevalence, prognosis and management of a potent cardiovascular risk factor.
    Norhammar A; Mellbin L; Cosentino F
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):52-60. PubMed ID: 28618910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Going low. This is your brain on hypoglycemia.
    Curry A
    Diabetes Forecast; 2015; 68(3):46-50. PubMed ID: 26668898
    [No Abstract]   [Full Text] [Related]  

  • 23. Incretin-based agents in type 2 diabetic patients at cardiovascular risk: compare the effect of GLP-1 agonists and DPP-4 inhibitors on cardiovascular and pancreatic outcomes.
    Zhang Z; Chen X; Lu P; Zhang J; Xu Y; He W; Li M; Zhang S; Jia J; Shao S; Xie J; Yang Y; Yu X
    Cardiovasc Diabetol; 2017 Mar; 16(1):31. PubMed ID: 28249585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Study of Postoperative Glycemic Control with a Standardized Insulin Infusion Protocol after Infrainguinal Bypass and Open Abdominal Aortic Aneurysm Repair.
    Steely AM; Smith L; Callas PW; Nathan MH; Lahiri JE; Stanley AC; Steinthorsson G; Bertges DJ
    Ann Vasc Surg; 2017 Oct; 44():211-220. PubMed ID: 28502888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of different statistical methods analyzing hypoglycemia data using bootstrap simulations.
    Jiang H; Ni X; Huster W; Heilmann C
    J Biopharm Stat; 2015; 25(1):54-65. PubMed ID: 24905704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
    Paty BW
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Underestimated risk for type 2 diabetic patients: danger due to hypoglycemia].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Apr; 152(17):12. PubMed ID: 20509251
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetes.
    Kang MY
    Korean J Intern Med; 2015 Sep; 30(5):648-56. PubMed ID: 26354059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The best defense against hypoglycemia is to recognize it: is caffeine useful?
    Watson J; Kerr D
    Diabetes Technol Ther; 1999; 1(2):193-200. PubMed ID: 11475292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of diabetes-related hypoglycemia.
    Boyle PJ; Zrebiec J
    South Med J; 2007 Feb; 100(2):183-94. PubMed ID: 17330689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation.
    Reno CM; Daphna-Iken D; Chen YS; VanderWeele J; Jethi K; Fisher SJ
    Diabetes; 2013 Oct; 62(10):3570-81. PubMed ID: 23835337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin pump therapy guidelines for China (July 2010).
    Mu Y; Yin S;
    J Diabetes; 2012 Jun; 4(2):127-39. PubMed ID: 22107806
    [No Abstract]   [Full Text] [Related]  

  • 33. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of the side effects of oral hypoglycemic agents in diabetes mellitus].
    Ishii J; Suzuki M
    Nihon Rinsho; 1990 Dec; 48 Suppl():955-61. PubMed ID: 2086978
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypoglycemia with intensive insulin therapy after cardiac surgery: predisposing factors and association with mortality.
    Stamou SC; Nussbaum M; Carew JD; Dunn K; Skipper E; Robicsek F; Lobdell KW
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):166-73. PubMed ID: 21397274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse causes of hypoglycemia-associated autonomic failure in diabetes.
    Cryer PE
    N Engl J Med; 2004 May; 350(22):2272-9. PubMed ID: 15163777
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of intracerebroventricular administration of the NPY-Y1 receptor antagonist, 1229U91, on hyperphagic and glycemic responses to acute and chronic intermediate insulin-induced hypoglycemia in female rats.
    Nedungadi TP; Briski KP
    Regul Pept; 2010 Jan; 159(1-3):14-8. PubMed ID: 19616044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemia and adverse outcomes: marker or mediator?
    Lipska KJ; Kosiborod M
    Rev Cardiovasc Med; 2011; 12(3):132-5. PubMed ID: 22080923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Approach to managing hypoglycemia in elderly patients with diabetes.
    Alagiakrishnan K; Mereu L
    Postgrad Med; 2010 May; 122(3):129-37. PubMed ID: 20463422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes.
    Færch LH; Thorsteinsson B; Tarnow L; Holst JJ; Kjær T; Kanters J; Larroude C; Dela F; Pedersen-Bjergaard U
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1036-45. PubMed ID: 25070348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.